Cancer Genomics: Deciphering Risk and Driving Discovery

Cancer has long been recognized as a genetic disease, from the discoveries of oncogenes and tumor suppressors, to hypothesis-driven work in model organisms. In recent years, scientists have been able to explore with unprecedented depth the genetic variation and mutational processes that promote tumor formation, progression, and evolution. In this AJHG-Cell Press Webinar, Stephen Chanock (National Cancer Institute), Kate Nathanson (University of Pennsylvania), and Peter Campbell (Wellcome Sanger Institute), will explore the ways in which genomic technology has transformed cancer research, leading to new biological insights and revolutionizing clinical practice.

Stephen Chanock
National Cancer Institute

Kate Nathanson
University of Pennsylvania

Peter Campbell
Wellcome Sanger Institute